Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency

Lin Yang(Panzhihua Central Hospital), G. Hu(Dalian University)
Oncology Reports
May 16, 2018
Cited by 45


Related Papers